63 related articles for article (PubMed ID: 38485945)
1. DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.
Yang Y; Gao M; Lin Z; Chen L; Jin Y; Zhu G; Wang Y; Jin T
Oncotarget; 2017 Nov; 8(58):98708-98722. PubMed ID: 29228721
[TBL] [Abstract][Full Text] [Related]
2. Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression.
Liu J; Chai XX; Qiu XR; Sun WJ; Tian YL; Guo WH; Yin DC; Zhang CY
Int J Biol Macromol; 2024 Jun; 273(Pt 1):133074. PubMed ID: 38866293
[TBL] [Abstract][Full Text] [Related]
3. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A.
Andriani L; Ling YX; Yang SY; Zhao Q; Ma XY; Huang MY; Zhang YL; Zhang FL; Li DQ; Shao ZM
Cancer Lett; 2024 Jun; 597():217008. PubMed ID: 38849012
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.
Zhang HP; Jiang RY; Zhu JY; Sun KN; Huang Y; Zhou HH; Zheng YB; Wang XJ
Breast Cancer; 2024 Jul; 31(4):539-551. PubMed ID: 38630392
[TBL] [Abstract][Full Text] [Related]
5. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway.
Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M
Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343
[TBL] [Abstract][Full Text] [Related]
6. Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway.
Li H; Liu Q; Hu Y; Yin C; Zhang Y; Gao P
Cell Death Discov; 2024 Mar; 10(1):138. PubMed ID: 38485945
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
[TBL] [Abstract][Full Text] [Related]
8. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
Yuan RX; Bao D; Zhang Y
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
[TBL] [Abstract][Full Text] [Related]
9. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Fan S; Yan S; Yang Y; Shang J; Hao M
Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
11. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.
Zheng H; Ge C; Lin H; Wu L; Wang Q; Zhou S; Tang W; Zhang X; Jin X; Xu X; Hong Z; Fu J; Du J
Int J Clin Oncol; 2022 Jul; 27(7):1145-1153. PubMed ID: 35397755
[TBL] [Abstract][Full Text] [Related]
13. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.
Ruiz-Fernández de Córdoba B; Moreno H; Valencia K; Perurena N; Ruedas P; Walle T; Pezonaga-Torres A; Hinojosa J; Guruceaga E; Pineda-Lucena A; Abengózar-Muela M; Cochonneau D; Zandueta C; Martínez-Canarias S; Teijeira Á; Ajona D; Ortiz-Espinosa S; Morales X; Ortiz de Solórzano C; Santisteban M; Ramos-García LI; Guembe L; Strnad V; Heymann D; Hervás-Stubbs S; Pío R; Rodríguez-Ruiz ME; de Andrea CE; Vicent S; Melero I; Lecanda F; Martínez-Monge R
Cancer Discov; 2022 May; 12(5):1356-1377. PubMed ID: 35191482
[TBL] [Abstract][Full Text] [Related]
14. Review of LINC00707: A Novel LncRNA and Promising Biomarker for Human Diseases.
Yao Q; Li Z; Chen D
Front Cell Dev Biol; 2022; 10():813963. PubMed ID: 35155429
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Chang CA; Jen J; Jiang S; Sayad A; Mer AS; Brown KR; Nixon AML; Dhabaria A; Tang KH; Venet D; Sotiriou C; Deng J; Wong KK; Adams S; Meyn P; Heguy A; Skok JA; Tsirigos A; Ueberheide B; Moffat J; Singh A; Haibe-Kains B; Khodadadi-Jamayran A; Neel BG
Cancer Discov; 2022 Apr; 12(4):1022-1045. PubMed ID: 34911733
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
